Most bought healthcare stocks in Q4 2024
Discover which Healthcare stocks institutional investors added to most aggressively over Q4 2024 versus the prior calendar quarter in our filings. Notable additions at the top of this list include AVANTOR INC (AVTR), CVS HEALTH CORP (CVS), BAXTER INTERNATIONAL INC (BAX), DR. REDDY'S LABORATORIES-ADR (RDY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share increases
Top symbols by net quarter-over-quarter share change (increases).
Most bought stocks
Net quarter-over-quarter share increases across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AVTR | AVANTOR INC | 26,951,502 | $168.6M | 1 | 5 | 3 | 2 | 11 |
| CVS | CVS HEALTH CORP | 13,136,346 | -$924.4M | 6 | 8 | 9 | 3 | 24 |
| BAX | BAXTER INTERNATIONAL INC | 9,742,791 | -$419.3M | 4 | 7 | 4 | 0 | 18 |
| RDY | DR. REDDY'S LABORATORIES-ADR | 7,967,009 | -$6.2M | 0 | 3 | 0 | 0 | 3 |
| HUM | HUMANA INC | 6,122,788 | $753.3M | 3 | 4 | 4 | 1 | 11 |
| ZOM | ZOMEDICA CORP | 4,120,642 | $490.8K | 1 | 0 | 0 | 0 | 2 |
| TVTX | TRAVERE THERAPEUTICS INC | 3,436,425 | $66.3M | 1 | 1 | 0 | 0 | 2 |
| TEM | TEMPUS AI INC | 3,141,487 | $51.7M | 0 | 1 | 0 | 0 | 1 |
| LLY | ELI LILLY & CO | 3,030,149 | $1.9B | 10 | 11 | 8 | 1 | 31 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 2,638,061 | $9.2M | 1 | 1 | 0 | 0 | 2 |
| CERS | CERUS CORP | 2,449,599 | $15.7K | 1 | 1 | 1 | 0 | 3 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 2,412,519 | $210.7M | 3 | 4 | 8 | 1 | 17 |
| OCGN | OCUGEN INC | 2,087,632 | $1.7M | 1 | 0 | 0 | 0 | 1 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 2,085,972 | $968.8K | 0 | 1 | 0 | 0 | 1 |
| COO | COOPER COS INC/THE | 2,022,032 | $172.9M | 2 | 3 | 2 | 0 | 7 |
| ABSI | ABSCI CORP | 1,928,314 | -$2.6M | 0 | 1 | 0 | 0 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1,667,720 | $313.7M | 3 | 2 | 3 | 1 | 8 |
| TXG | 10X GENOMICS INC-CLASS A | 1,631,055 | -$65.2M | 1 | 2 | 1 | 0 | 5 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,626,485 | -$3.3M | 1 | 5 | 2 | 1 | 8 |
| GILD | GILEAD SCIENCES INC | 1,612,571 | $492.7M | 3 | 9 | 6 | 1 | 19 |
| ZTS | ZOETIS INC | 1,517,279 | -$125.3M | 3 | 10 | 3 | 0 | 19 |
| SENS | SENSEONICS HOLDINGS INC | 1,506,650 | $788.6K | 2 | 0 | 0 | 0 | 2 |
| BSX | BOSTON SCIENTIFIC CORP | 1,500,901 | $161.2M | 4 | 8 | 3 | 1 | 17 |
| GERN | GERON CORP | 1,452,700 | $5.1M | 1 | 0 | 0 | 0 | 1 |
| EDIT | EDITAS MEDICINE INC | 1,451,049 | $1.8M | 1 | 0 | 0 | 0 | 2 |
| LYEL | LYELL IMMUNOPHARMA INC | 1,414,746 | $759.4K | 0 | 1 | 0 | 0 | 1 |
| FOLD | AMICUS THERAPEUTICS INC | 1,407,396 | $12.1M | 1 | 3 | 0 | 0 | 4 |
| VRTX | VERTEX PHARMACEUTICALS INC | 1,399,475 | $425.3M | 4 | 5 | 7 | 1 | 16 |
| WRBY | WARBY PARKER INC-CLASS A | 1,393,209 | $115.0M | 1 | 3 | 1 | 0 | 5 |
| EVH | EVOLENT HEALTH INC - A | 1,385,169 | -$52.9M | 0 | 1 | 1 | 0 | 2 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 1,281,000 | $3.4M | 1 | 1 | 0 | 0 | 2 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 1,216,332 | $67.4M | 1 | 3 | 3 | 1 | 8 |
| ELV | ELEVANCE HEALTH INC | 1,189,746 | -$799.3M | 5 | 7 | 7 | 2 | 24 |
| GSK | GSK PLC-SPON ADR | 971,635 | -$473.0M | 2 | 5 | 3 | 0 | 12 |
| DXCM | DEXCOM INC | 948,754 | $96.9M | 4 | 6 | 2 | 0 | 12 |
| SOLV | SOLVENTUM CORP | 932,564 | $59.5M | 3 | 4 | 3 | 2 | 10 |
| LEGN | LEGEND BIOTECH CORP-ADR | 893,557 | $28.4M | 1 | 2 | 0 | 0 | 4 |
| BNTX | BIONTECH SE-ADR | 892,201 | $101.4M | 0 | 1 | 2 | 0 | 3 |
| TMO | THERMO FISHER SCIENTIFIC INC | 881,831 | -$43.5M | 9 | 10 | 8 | 0 | 30 |
| TSHA | TAYSHA GENE THERAPIES INC | 878,447 | $1.5M | 1 | 0 | 1 | 0 | 3 |
| RLAY | RELAY THERAPEUTICS INC | 873,895 | $1.6M | 0 | 1 | 0 | 1 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 869,949 | -$213.4K | 0 | 1 | 0 | 0 | 2 |
| DHR | DANAHER CORP | 854,015 | -$171.5M | 4 | 8 | 5 | 2 | 22 |
| ACAD | ACADIA PHARMACEUTICALS INC | 825,189 | $16.3M | 1 | 1 | 0 | 0 | 2 |
| JNJ | JOHNSON & JOHNSON | 810,495 | -$21.7M | 8 | 11 | 9 | 1 | 35 |
| TDOC | TELADOC HEALTH INC | 743,817 | $6.3M | 1 | 1 | 3 | 0 | 6 |
| ILMN | ILLUMINA INC | 715,928 | $34.8M | 4 | 3 | 5 | 0 | 12 |
| IPSC | CENTURY THERAPEUTICS INC | 714,685 | $380.1K | 0 | 1 | 0 | 0 | 1 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 680,965 | $9.0M | 1 | 0 | 0 | 0 | 1 |
| DCGO | DOCGO INC | 662,490 | $2.9M | 2 | 1 | 0 | 0 | 3 |